Nationwide recall issued for this thyroid medication. See products

Key Points:

• Major Rugby has issued a nationwide recall of 12 levothyroxine sodium tablet packages, used to treat hypothyroidism and other thyroid conditions, due to the tablets being subpotent and delivering less medication than required.
• The recalled products, sold under the Major and Cardinal brand names, were distributed across the U.S. starting January 2025 and include various dosages ranging from 25 mcg to 150 mcg in blister packs and cartons.
• Although Major Rugby states that taking the recalled medication is unlikely to cause adverse health effects, consumers are advised to return the products to their point of purchase and consult their healthcare provider.
• The recall covers specific lot numbers and expiration dates for both 100-tablet packs and 10-tablet unit dose blisters, with detailed information provided to retailers and consumers for identification.
• Patients using levothyroxine sodium tablets from the affected lots should check their medication and contact their doctor to ensure proper thyroid treatment continuity.